当前位置:首页 - 行情中心 - 药康生物(688046) - 财务分析

药康生物

(688046)

  

流通市值:59.45亿  总市值:59.45亿
流通股本:4.10亿   总股本:4.10亿

药康生物(688046)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.30亿元,每股收益0.07元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益216192.13万元,未分配利润46528.76万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产265096.43万元,负债48904.30万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入170,855,596.98686,837,009.6509,718,216.98340,382,982.48
营业总成本135,710,404.13580,186,527.9414,793,749.59267,437,468.2
营业利润30,673,653.95119,367,805.5799,210,739.4677,417,917.44
利润总额30,673,653.96119,214,997.9499,198,919.0177,410,385.43
净利润29,980,260.4109,819,819.398,214,378.676,337,717.64
其他综合收益-98,315.247,553,752.88-198,986.15138,212.38
综合收益总额29,881,945.16117,373,572.1898,015,392.4576,475,930.02
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,719,421,426.161,709,773,844.341,677,726,535.051,744,108,283.12
非流动资产合计931,542,907.09862,871,431.31855,813,951.11870,078,530.51
资产总计2,650,964,333.252,572,645,275.652,533,540,486.162,614,186,813.63
流动负债合计397,976,772.17371,195,620.33341,384,959.63426,643,634.88
非流动负债合计91,066,227.4466,723,335.7168,841,336.474,342,950.01
负债合计489,042,999.61437,918,956.04410,226,296.03500,986,584.89
归属于母公司股东权益合计2,161,921,333.642,134,726,319.612,123,314,190.142,113,200,228.74
股东权益合计2,161,921,333.642,134,726,319.612,123,314,190.142,113,200,228.74
负债和股东权益合计2,650,964,333.252,572,645,275.652,533,540,486.162,614,186,813.63
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计141,686,709.44674,117,821.39420,477,343.76248,372,539.7
经营活动现金流出小计168,414,315.17583,803,561.86436,378,303.47291,937,221.43
经营活动产生的现金流量净额-26,727,605.7390,314,259.53-15,900,959.72-43,564,681.74
投资活动现金流入小计375,409,357.781,918,676,148.341,421,657,306.961,318,968,360.35
投资活动现金流出小计752,289,074.171,759,783,304.331,368,772,565.081,069,473,029.32
投资活动产生的现金流量净额-376,879,716.39158,892,844.0152,884,741.88249,495,331.03
筹资活动现金流入小计119,450,00097,950,00067,950,00067,950,000
筹资活动现金流出小计72,664,988.68206,894,763.94172,900,850.8963,866,299.11
筹资活动产生的现金流量净额46,785,011.32-108,944,763.94-104,950,850.894,083,700.89
汇率变动对现金及现金等价物的影响532,829.53959,889.98-1,355,366.52255,801.36
现金及现金等价物净增加额-356,289,481.27141,222,229.58-69,322,435.25210,270,151.54
期末现金及现金等价物余额344,935,989.46701,215,442.73490,670,777.9770,263,364.69
最新报告期:2025-05-07
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券陈竹,王凯旋,韩世通0.330.390.462025-05-07
野村东方国际证券孔令岩,朱小溪0.320.400.482025-05-06
华安证券谭国超0.320.410.472025-04-30
东吴证券朱国广0.320.390.482025-04-29
国信证券马千里0.320.400.462025-04-29
TOP↑